Check out your Company Bowl for anonymous work chats.
#Oncology does not slow down. ASCO is where you see how fast it is moving. In 11 days, data will be presented in Chicago that did not exist as clinical evidence a year ago. Treatments that were in early trials will become serious options. Questions that kept investigators up at night will get answers. This is the best week in cancer research: Estelle and Ibrahim will be there representing TFS, because translating what happens at hashtag#ASCO26 into running trials is what we do. Swipe to hear from Estelle, our Interim Head of Oncology, on what this year's meeting means for her and for the field.
When your CEO flies to Barcelona to be on the booth with the team, you know something is happening. Markus Granlund is here at OCT because the momentum this week is worth showing up for. Our team is building the partnerships that bring new treatments to patients faster.
Spending time together is always a great reminder of what makes our culture special. Take a look at some of our colleagues in Barcelona sharing conversations, perspectives, and a few laughs along the way.
The way we work together matters. At TFS, mutual support, passion and trust is what allows teams to do their work well and create real impact. Listen to what Ines Morales has to say. Our commitment to excellence drives us to support our clients with agility while championing a sustainable future for all. Do you want to join a community of dedicated individuals committed to advancing clinical research and transforming challenges into opportunities? Explore our opportunities: https://bit.ly/43VfXeH
Meet TFS’s experienced CRO team and explore our specialized clinical development and resourcing solutions that keep your trial moving forward.
Markus Granlund, CEO, sharing his outlook on the upcoming year.
Miriam Martin, VP, Business Development, reflecting on the previous year.
Estelle Guiheneuf, Interim Head of Oncology, reflecting on the previous year.
Marcia Swank, VP, Ophthalmology, reflecting on the previous year.
Hanna Sandvall, VP, SRS, reflecting on the previous year.
